Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4

NATURE GENETICS ADVANCE ONLINE PUBLICATION 1 We conducted a combined genome-wide association study (GWAS) of 7,481 individuals with bipolar disorder (cases) and 9,250 controls as part of the Psychiatric GWAS Consortium. Our replication study tested 34 SNPs in 4,496 independent cases with bipolar disorder and 42,422 independent controls and found that 18 of 34 SNPs had P < 0.05, with 31 of 34 SNPs having signals with the same direction of effect (P = 3.8 × 10−7). An analysis of all 11,974 bipolar disorder cases and 51,792 controls confirmed genome-wide significant evidence of association for CACNA1C and identified a new intronic variant in ODZ4. We identified a pathway comprised of subunits of calcium channels enriched in bipolar disorder association intervals. Finally, a combined GWAS analysis of schizophrenia and bipolar disorder yielded strong association evidence for SNPs in CACNA1C and in the region of NEK4-ITIH1-ITIH3-ITIH4. Our replication results imply that increasing sample sizes in bipolar disorder will confirm many additional loci.

[1]  John P. Rice,et al.  Genome-wide association study of bipolar disorder in European American and African American individuals , 2009, Molecular Psychiatry.

[2]  Joseph H Callicott,et al.  Genetic variation in CACNA1C affects brain circuitries related to mental illness. , 2010, Archives of general psychiatry.

[3]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[4]  Tilo Kircher,et al.  Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals , 2010, NeuroImage.

[5]  N. Craddock,et al.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis , 2005, Journal of Medical Genetics.

[6]  M C O'Donovan,et al.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia , 2009, Molecular Psychiatry.

[7]  S. Cichon,et al.  Genomewide association studies: history, rationale, and prospects for psychiatric disorders. , 2009, The American journal of psychiatry.

[8]  S. Cichon,et al.  Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder , 2008, Molecular Psychiatry.

[9]  P. Janicak,et al.  Calcium channel antagonists for the treatment of bipolar disorder. , 2000, Bipolar disorders.

[10]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[11]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[12]  David Curtis,et al.  Case–case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes , 2011, Psychiatric genetics.

[13]  Robert C. Thompson,et al.  Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry , 2009, Proceedings of the National Academy of Sciences.

[14]  N. Craddock,et al.  Genetics of bipolar disorder. , 2010, Journal of medical genetics.

[15]  N. Craddock,et al.  Genetics of bipolar disorder: successful start to a long journey. , 2009, Trends in genetics : TIG.

[16]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[17]  R. Dolmetsch,et al.  The C Terminus of the L-Type Voltage-Gated Calcium Channel CaV1.2 Encodes a Transcription Factor , 2006, Cell.

[18]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[19]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[20]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[21]  T. Werge,et al.  CACNA1C (rs1006737) is associated with schizophrenia , 2010, Molecular Psychiatry.

[22]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. , 2011, American journal of human genetics.

[23]  J. Stockman,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2010 .

[24]  S. Djurovic,et al.  A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. , 2010, Journal of affective disorders.

[25]  John P. Rice,et al.  Singleton deletions throughout the genome increase risk of bipolar disorder , 2009, Molecular Psychiatry.

[26]  E. Vassos,et al.  Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. , 2009, The American journal of psychiatry.

[27]  Peter Kirsch,et al.  Brain function in carriers of a genome-wide supported bipolar disorder variant. , 2010, Archives of general psychiatry.